Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(6)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07465627Not Yet Recruiting

Vessel Recoil in Specific CLTI Populations

Role: collaborator

NCT06122974Not ApplicableNot Yet Recruiting

Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

Role: lead

NCT05358353Not ApplicableCompleted

A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)

Role: lead

NCT06117150Phase 1Active Not Recruiting

Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)

Role: lead

NCT05848232Phase 3Unknown

Single-Arm Study Evaluating Use of the CORA Catheters for the Crossing of Coronary Chronic Total Occlusions

Role: lead

NCT04162418Not ApplicableCompleted

A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB

Role: lead

NCT03807531Not ApplicableActive Not Recruiting

A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee

Role: lead

NCT03403426Not ApplicableCompleted

ReFlow Medical Wingman Catheter Wing-IT Clinical Trial

Role: lead

NCT03669458Not ApplicableCompleted

Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy.

Role: lead

All 9 trials loaded